BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25671577)

  • 1. Human T cell crosstalk is induced by tumor membrane transfer.
    Uzana R; Eisenberg G; Merims S; Frankenburg S; Pato A; Yefenof E; Engelstein R; Peretz T; Machlenkin A; Lotem M
    PLoS One; 2015; 10(2):e0118244. PubMed ID: 25671577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis.
    Gary R; Voelkl S; Palmisano R; Ullrich E; Bosch JJ; Mackensen A
    J Immunol; 2012 Jan; 188(2):744-52. PubMed ID: 22174448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clones.
    Uzana R; Eisenberg G; Sagi Y; Frankenburg S; Merims S; Amariglio N; Yefenof E; Peretz T; Machlenkin A; Lotem M
    J Immunol; 2012 Jan; 188(2):632-40. PubMed ID: 22156347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
    Chang J
    Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
    Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
    Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
    Machlenkin A; Uzana R; Frankenburg S; Eisenberg G; Eisenbach L; Pitcovski J; Gorodetsky R; Nissan A; Peretz T; Lotem M
    Cancer Res; 2008 Mar; 68(6):2006-13. PubMed ID: 18339883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaping of T Cell Functions by Trogocytosis.
    Nakayama M; Hori A; Toyoura S; Yamaguchi SI
    Cells; 2021 May; 10(5):. PubMed ID: 34068819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
    Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
    Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
    Riond J; Elhmouzi J; Hudrisier D; Gairin JE
    Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
    Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
    J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
    Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3 mediates T cell trogocytosis to limit antitumor immunity.
    Pagliano O; Morrison RM; Chauvin JM; Banerjee H; Davar D; Ding Q; Tanegashima T; Gao W; Chakka SR; DeBlasio R; Lowin A; Kara K; Ka M; Zidi B; Amin R; Raphael I; Zhang S; Watkins SC; Sander C; Kirkwood JM; Bosenberg M; Anderson AC; Kuchroo VK; Kane LP; Korman AJ; Rajpal A; West SM; Han M; Bee C; Deng X; Schebye XM; Strop P; Zarour HM
    J Clin Invest; 2022 May; 132(9):. PubMed ID: 35316223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
    Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
    Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
    Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.